Globalstar heads into the week having barely moved — down 0.13% — yet its EPS momentum story is among the strongest in the market, creating a visible tension with a multiple that demands perfection.
The EPS picture is the standout signal right now. GSAT ranks in the 100th percentile for 30-day EPS momentum and the 99th percentile for EPS surprise, meaning the company has been consistently beating estimates at a rate that almost nothing else can match. Forward EPS is running 87% higher year-on-year. That's the bull case in compressed form: the earnings revision cycle is working hard in the stock's favour, and the market has been rewarding it — the stock is up 34% year-to-date, closing Friday at $81.98.
The short setup offers little drama at this level. Short interest is a modest 2.7% of free float — up 5% on the week but coming off a lower base after a 2% decline over the prior month. That is not a heavily shorted name. Borrow conditions are relaxed: availability is wide, and the cost to borrow at 0.60% is essentially negligible even after roughly doubling over seven days. The ORTEX short score of 44.3 out of 100 reflects a relatively subdued short-side setup. Options traders are similarly unmoved. The put/call ratio of 0.42 is fractionally below its 20-day average of 0.43, with a z-score near zero — no unusual hedging demand, no directional bet from the derivatives market.
Where the story gets complicated is valuation. GSAT trades at an EV/EBITDA of roughly 67–69x and an EV/revenue of 34x against estimated revenue of ~$299 million. Net income remains negative at -$49 million. The P/E on a last-close basis is around 155x. These are multiples that assume a very long runway of high-margin growth — any miss on execution shows up immediately in the stock. The EV/EBIT factor score ranks in the 2nd percentile, flagging how stretched the multiple is relative to the universe. Bulls point to the Apple satellite connectivity deal as a structural re-rating catalyst; bears note that $10 billion in enterprise value against sub-$300 million in revenue is a steep price for a company still burning cash on a net income basis.
The analyst data here carries a caveat: the most recent changes are from November 2025, with B. Riley maintaining Buy and raising its target to $75. The current stock price of $81.98 has already blown through those targets, so street estimates are stale relative to where the stock trades. The mean price target of $90 implies roughly 10% upside, but given the gap between when those targets were set and the stock's subsequent rally, the figure deserves scepticism. No bellwether firm action has crossed the tape in the past 14 days.
Institutional ownership reflects a highly concentrated structure. James Monroe controls 57.5% of shares. The next largest holders — Vanguard at 3.9% and BlackRock at 3.3% — have been adding modestly. FMR (Fidelity) added nearly 695,000 shares as of April 30, the largest incremental purchase in the holder list. On the insider side, CFO Rebecca Clary received equity awards in both mid-April and late April before selling approximately 8,000 shares across two transactions at prices around $79–81 — routine post-award sales rather than a signal of conviction either way.
Next earnings is scheduled for August 5. The last print on May 13 produced a muted one-day move of -0.7%. The February result moved the stock 7% higher on day one before giving back 2.5% over the following week. With the Q1 2026 report now in the rearview, the next catalyst window is squarely in August — and by then the market will want to see whether the revenue and EBITDA trajectory justifies what is already a demanding multiple.
See the live data behind this article on ORTEX.
Open GSAT on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
